Related Experiment Video
Updated: Mar 7, 2026

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Published on: December 20, 2019
Rab7A regulates tau secretion
Lilia Rodriguez1,2,3, Nguyen-Vi Mohamed1,2,3, Alexandre Desjardins1,2,3
1Research Center of the University of Montreal Hospital (CRCHUM), Montréal, Québec, Canada.
Abstract:
The axonal microtubule-associated protein TAU, involved in Alzheimer's disease (AD), can be found in the extracellular space where it could be taken up by neurons, an event that is believed to contribute to the propagation of tau pathology in the brain. Since the small GTPase Rab7A is involved in the trafficking of endosomes, autophagosomes, and lysosomes, and RAB7A gene expression and protein levels are up-regulated in AD patients, we tested the hypothesis that Rab7A was involved in tau secretion. We previously reported that both primary cortical neurons and HeLa cells over-expressing human TAU can release tau. Using these two cellular systems, we demonstrated that Rab7A regulates tau secretion. Upon Rab7A deletion, tau secretion was decreased. Consistent with this, the over-expression of a dominant negative and a constitutively active form of Rab7A decreased and increased tau secretion, respectively. A partial co-localization of tau and Rab7-positive structures in both neurons and HeLa cells indicated that a late endosomal compartment could be involved in its secretion. Collectively, the present data indicate that Rab7A regulates tau secretion and therefore the up-regulation of RAB7A reported in AD, could contribute to the extracellular accumulation of pathological TAU species that could result in the propagation of tau pathology in the AD brain.
Insights
Rab7A regulates the secretion of TAU protein, a key factor in Alzheimer's disease (AD) pathology. This finding suggests that increased RAB7A in AD brains may worsen TAU spread and disease progression.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- TAU protein is implicated in Alzheimer's disease (AD) and can spread extracellularly.
- Rab7A, a small GTPase, is involved in intracellular trafficking and is upregulated in AD.
Purpose of the Study:
- To investigate the role of Rab7A in the secretion of TAU protein.
- To test the hypothesis that Rab7A regulates TAU secretion.
Main Methods:
- Utilized primary cortical neurons and HeLa cells overexpressing human TAU.
- Assessed TAU secretion following Rab7A deletion or manipulation of its activity (dominant-negative and constitutively active forms).
- Examined co-localization of TAU and Rab7-positive structures.
Main Results:
- Rab7A deletion significantly decreased TAU secretion.
- Overexpression of dominant-negative Rab7A reduced TAU secretion, while constitutively active Rab7A increased it.
- Partial co-localization of TAU and Rab7 suggests involvement of late endosomes in secretion.
Conclusions:
- Rab7A plays a regulatory role in TAU secretion.
- Upregulation of RAB7A in AD may contribute to extracellular TAU accumulation and pathology propagation.

